UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) ~~September~~November 124, 2016

Commission file number: 000-55493

~~ANDES~~Andes 9, Inc.

(Exact name of registrant as specified in its charter)

Delaware		47-~~4706471~~4694442
(State or other jurisdiction		(IRS Employer
of incorporation or organization)		Identification number)
Kerry Center 2501-2502 South Renmin Rd.
Room 01 25/F Kerry Ctr No 2008 Renmin South Rd Luohu District.
Shenzhen Guangzhou		n/a
Shenzhen Guangzhou, China		n/a
(Address of Principal Executive Offices)		(Zip Code)

86-0755-~~2188~~2218-4466

(Registrant’s Telephone Number, Including Area Code)

~~16192 Coastal Highway~~NA

Lewes DE 19958

(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

☐ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

-1-

ITEM 34.0201 ~~Unregistered~~Change ~~Sales~~in ofRegistrant’s ~~Equity~~Certifying ~~Securities~~Accountant

On ~~September~~November 124, 2016, ~~ANDES~~the 9Board of ~~Inc.~~Directors (approved the engagement of Fruci & Associates II, PLLC (“~~Company~~Fruci”) ~~entered~~ ~~into~~as athe ~~Subscription~~Company’s ~~Agreement~~independent registered ~~with~~public ~~Dongzhi~~accounting ~~Zhang~~firm for the ~~purchase~~Company’s offiscal 20year ~~million~~ended ~~shares~~December of31, ~~its~~2016, ~~restricted~~effective ~~common~~immediately, ~~stock~~and atdismissed aGillespie ~~price~~& ofAssociates ~~$0.0001~~(“Gillespie”) ~~per~~as ~~share.~~the ~~The~~Company's ~~sale~~independent ~~was~~registered ~~the~~public ~~result~~accounting offirm. aGillespie’s review ~~privately~~of ~~negotiated~~the ~~transaction~~Company’s ~~without~~consolidated ~~the~~financial ~~use~~statements ofas ~~public dissemination~~ of ~~promotional~~and orfor ~~sales~~the ~~materials.~~periods ~~The~~of ~~buyer~~March ~~represented~~31, ~~that~~2016 heand ~~was~~June an30, ~~“accredited~~2016 ~~investors,”~~did not ~~and~~contain asan ~~such~~adverse ~~could~~opinion ~~bear the~~or ~~risk~~a disclaimer of ~~such~~opinion ~~investment~~and ~~for~~were annot ~~indefinite~~qualified ~~period~~or ofmodified ~~time~~as ~~and~~ to ~~afford~~uncertainty, aaudit ~~complete~~scope ~~loss~~or accounting ~~thereof~~principles.

The ~~sale~~former toAccountant ~~Mr. Zhang~~ was ~~exempt from registration~~engaged ~~under~~on ~~section~~April ~~4(2)~~28, ~~of the Securities Act of 1933~~2016. ~~Mr.~~During ~~Zhang and~~ the ~~Company~~fiscal ~~agreed~~year ~~that~~ended ~~the~~December ~~Company~~31, ~~would legend the securities to indicate that they could not be resold without an exemption~~2015, and ~~that~~ the ~~legend~~subsequent ~~would~~interim ~~indicate~~periods ~~that~~through ~~the~~November ~~securities~~3, 2016, there were ~~“restricted securities”~~(i) ~~within~~no ~~the~~disagreements ~~meaning~~(as ofdescribed ~~Rule~~in ~~144~~Item 304(a)(~~iii~~1).(iv) ~~The~~of ~~buyer~~Regulation ~~represented~~S-K) ~~and~~between ~~warranted~~the ~~that~~Company heand ~~was~~Gillespie ~~purchasing~~on ~~the security~~any ~~for~~matter ~~investment,~~of ~~and~~accounting ~~not~~principles ~~for~~or ~~distribution~~practices, ~~and~~financial ~~that~~statement hedisclosure, ~~understood~~or ~~the~~auditing ~~restrictions~~scope onor ~~transfer~~procedure, ~~applicable~~which, toif ~~the~~not ~~securities, and~~resolved ~~that~~to ~~the~~Gillespie’s ~~Company~~satisfaction, would ~~code~~have ~~the~~caused ~~securities~~Gillespie soto ~~that~~make ~~they~~reference ~~could~~thereto ~~not~~in betheir ~~transferred~~reports ~~without~~on the ~~transferor~~financial ~~obtaining~~statements for ansuch ~~opinion~~years, ~~of counsel~~and ~~satisfactory~~(ii) tono ~~the~~“reportable ~~Company.~~events” ~~Mr.~~within ~~Zhang~~the ~~used~~meaning ~~personal~~of ~~funds~~Item to304(a)(1)(v) ~~make~~of ~~the purchase~~Regulation.

OnDuring ~~September~~the 12fiscal year ended December 31, ~~2016~~2015, ~~Richard~~and ~~Chiang,~~the ~~our then~~subsequent ~~sole~~interim ~~shareholder,~~periods ~~officer~~through ~~and~~November ~~director~~3, ~~and~~2016, neither the Company ~~agreed~~nor toanyone acting on its behalf has consulted with Fruci regarding (i) the ~~redemption~~application of 10accounting principles to a specific transaction,~~000~~ either completed or proposed,~~000~~ ~~shares~~or the type of audit opinion that might be rendered on the Company’s financial statements or the effectiveness ~~common~~of ~~stock~~internal atcontrol ~~par~~over ~~value~~financial reporting, ~~i.e.~~and ~~$1,000,~~neither ~~which~~a ~~had~~written ~~previously~~report ~~been~~or ~~issued~~oral advice was provided to ~~Mr.~~the ~~Chiang.~~Company ~~The~~that Fruci concluded was an important factor considered by the Company ~~has~~in noreaching ~~disputes~~a decision as to any accounting, auditing, or ~~disagreements~~financial ~~with~~reporting ~~Mr.~~issue, ~~Chiang.~~(ii) Inany ~~order~~matter tothat ~~effectuate~~was the ~~redemption,~~subject ~~Mr.~~of ~~Chiang~~a ~~subsequently~~disagreement ~~returned~~within the ~~stock~~meaning ~~certificate~~of ~~representing~~Item ~~the~~304(a)(1)(iv) of Regulation 10S-K,~~000,000~~ ~~shares~~or (iii) any reportable event within the meaning of Item 304(a)(1)(v) of Regulation S-K.

~~ITEM~~On ~~5.01~~November ~~Change~~8, 2016, the Company provided Gillespie with a copy of the disclosures it is making in ~~Control~~this Current Report on Form 8-K and requested that Gillespie furnish a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the statements made herein. A copy of ~~Registrant~~Gillespie’s letter dated November 9, 2016, is filed as Exhibit 16.1 hereto.

~~ITEM~~Section ~~5.02~~9 ~~Departure~~– ofFinancial ~~Directors~~Statements orand ~~Principal Officers; Election of Directors~~Exhibits

On September 12, 2016, our board appointed Dongzhi Zhang to our board. Immediately thereafter, Richard Chiang resigned as our CEO and CFO and our board appointed Mr. Zhang to both of those offices, following which Mr. Chiang resigned from our board and from all remaining offices with the Company. There were no disagreements with Mr. Chiang. Mr. Zhang is also our sole shareholder as a result of the transactions described under items 1.01 and 3.02, above.

The Company remains a shell company within the meaning of Rule 12b-2 and a blank check company within the meaning of section 3(a)(51) of the Exchange Act and does not contemplate any immediate change to its business plan or operations as previously disclosed on its Form 10-12G/A filed September 8, 2015.

Mr. Zhang, age 55, has served as President of Zhongnan International Investment Group Co., Ltd. since 2010. He graduated from the Central Police University and minored in Executive Master Business Administration at Yangtze University. From 1979 to 1996, he worked as the president of Jiangsu Changzhou Wujin Sugar, Tobacco and Alcohol Co., Ltd; from 1996 to 2010, he worked as the General Manager at Beijing Jianghong Investment Co., Ltd. Mr. Zhang was honored with Changzhou’s Model Worker and the Outstanding Entrepreneur in Jiangsu Province. The Company believes Mr. Zhang would be a valuable addition to our board because of his international business experience and contacts.

Section 9 – Financial Statements and Exhibits

ITEM 9.01 Financial Statement and Exhibits.

Exhibit No.	Exhibit
17.1	Resignation, Richard Chiang
16.1	Auditor Letter- Gillespie & Associates dated November 9, 2016
99.4	Stock Subscription Agreement, Dongzhi Zhang

-2-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

~~ANDES~~Andes 9, Inc.

By: /s/ Dongzhi Zhang

Name: Dongzhi Zhang

Title: President, Chief Executive Officer, and Chairman of the Board of Directors

Date: ~~September~~ 19November 9, 2016

-3-

Filing Compare · ZhongTai Biotechnology Pharmaceutical Group Co., Ltd